{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:03:40Z","timestamp":1791205420994,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.biopsych.2008.09.009","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T08:22:26Z","timestamp":1225527746000},"page":"169-174","source":"Crossref","is-referenced-by-count":67,"title":["Delta-Opioid Receptor Antagonists Prevent Sensitization to the Conditioned Rewarding Effects of Morphine"],"prefix":"10.1016","volume":"65","author":[{"given":"Toni S.","family":"Shippenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Chefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2008.09.009_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1749-6632.1992.tb25984.x","article-title":"Classical conditioning in drug-dependent humans","volume":"654","author":"O'Brien","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib2","first-page":"71","article-title":"Developing treatments that address classical conditioning","volume":"135","author":"O'Brien","year":"1993","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.biopsych.2008.09.009_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: What does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2008.09.009_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","article-title":"Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues","volume":"56","author":"Tzschentke","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02244201","article-title":"Role of repeated exposure to morphine in determining its affective properties: Place and taste conditioning studies in rats","volume":"103","author":"Gaiardi","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2008.09.009_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00451687","article-title":"Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine","volume":"98","author":"Lett","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2008.09.009_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(95)00852-7","article-title":"Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal characteristics","volume":"299","author":"Shippenberg","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.pbb.2005.01.003","article-title":"Morphine pre-exposure facilitates morphine place preference and attenuates morphine taste aversion","volume":"80","author":"Simpson","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2008.09.009_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0304-3940(93)90329-J","article-title":"Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat","volume":"153","author":"Spanagel","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2008.09.009_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0361-9230(95)02092-6","article-title":"An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice","volume":"39","author":"Kest","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2008.09.009_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0022-3565(24)36506-1","article-title":"Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors","volume":"280","author":"Sanchez-Blazquez","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.09.009_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(00)80836-3","article-title":"Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice","volume":"24","author":"Zhu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2008.09.009_bib13","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1523\/JNEUROSCI.21-19-07598.2001","article-title":"Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception","volume":"21","author":"Cahill","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tips.2006.11.003","article-title":"Trafficking of delta-opioid receptors and other G-protein-coupled receptors: Implications for pain and analgesia","volume":"28","author":"Cahill","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2008.09.009_bib16","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1074\/jbc.M500171200","article-title":"Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions","volume":"280","author":"Law","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2008.09.009_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(25)10315-7","article-title":"Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors","volume":"263","author":"Porreca","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.09.009_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0196-9781(93)90064-N","article-title":"Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: Further evidence for delta receptor heterogeneity","volume":"14","author":"Xu","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2008.09.009_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(88)90502-X","article-title":"Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist","volume":"146","author":"Portoghese","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(25)24699-7","article-title":"Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes","volume":"257","author":"Sofuoglu","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.09.009_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(92)90167-3","article-title":"A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone","volume":"218","author":"Portoghese","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(97)01614-2","article-title":"Sensitization to the conditioned rewarding effects of morphine and cocaine: Differential effects of the kappa-opioid receptor agonist U69593","volume":"345","author":"Shippenberg","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00432213","article-title":"Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning","volume":"86","author":"Mucha","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2008.09.009_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(95)00185-N","article-title":"The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine","volume":"280","author":"Shippenberg","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1476-5381.1992.tb12785.x","article-title":"Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats","volume":"107","author":"Crook","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(92)90356-9","article-title":"Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation","volume":"216","author":"Baamonde","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0024-3205(92)90138-F","article-title":"Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone","volume":"50","author":"Takemori","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(92)90129-R","article-title":"Antinociception after intracerebroventricular administration of naltrindole in the mouse","volume":"214","author":"Stapelfeld","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0022-3565(24)29492-1","article-title":"Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu\/delta\/kappa-opioid receptor knockout mice reveal a nonopioid activity","volume":"298","author":"Gaveriaux-Ruff","year":"2001","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.biopsych.2008.09.009_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.pa.36.040196.002115","article-title":"Opioid receptor types and subtypes: The delta receptor as a model","volume":"36","author":"Zaki","year":"1996","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib31","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1021\/jm0342358","article-title":"A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes","volume":"47","author":"Bhushan","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2008.09.009_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(03)01599-1","article-title":"Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord","volume":"467","author":"Portoghese","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.105.012070","article-title":"Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells","volume":"68","author":"Xie","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.09.009_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0006-8993(96)01119-5","article-title":"Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by delta opioid receptor subtypes in mice","volume":"744","author":"Suzuki","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2008.09.009_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2007.02.040","article-title":"Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores","volume":"566","author":"Leonard","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib37","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1460-9568.2003.02912.x","article-title":"Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice","volume":"18","author":"Chefer","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1254\/jjp.66.131","article-title":"Blockade of delta opioid receptors prevents morphine-induced place preference in mice","volume":"66","author":"Suzuki","year":"1994","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib39","article-title":"Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice","author":"Chefer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2008.09.009_bib40","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/mol.105.019109","article-title":"Emergence of functional delta opioid receptors induced by long-term treatment with morphine","volume":"69","author":"Ma","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2008.09.009_bib41","doi-asserted-by":"crossref","first-page":"26128","DOI":"10.1074\/jbc.M000345200","article-title":"Oligomerization of mu- and delta-opioid receptors","volume":"275","author":"George","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2008.09.009_bib42","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","article-title":"Heterodimerization of mu and delta opioid receptors: A role in opiate synergy","volume":"20","author":"Gomes","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.09.009_bib43","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1073\/pnas.0506627102","article-title":"Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","volume":"102","author":"Daniels","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2008.09.009_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322308011013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322308011013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T13:16:48Z","timestamp":1738502208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322308011013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0006322308011013"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2008.09.009","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}